News
Cancer HorizonsAll NewsBlogsCaregivingDiet and ExerciseFinancialPsychosocialRecipesSexual HealthSide EffectSponsoredSurvivorship
Videos
All VideosCURE ConnectionsCURE Expert Connections®CURE Speaking OutCURE TVEducated Patient Sound BitesOn Demand: Webinars
Conferences
Conference Coverage Conference Listing
Events
CURE AdventuresCURE AwardsEducated Patient In Person EducationEducated Patient Virtual Education
More
Resources
Advocacy GroupsArt GalleryClinical Trial CornerHeal®PartnersPodcastsPublicationsShare Your Story

Subscribe

  • News
  • Videos
  • Conferences
  • Events
  • Resources
  • Subscribe
  • Blood Cancers
    • MPN
    • MDS
    • Myeloma
  • Brain Cancer
  • Breast Cancer
    • Metastatic Breast Cancer
  • Childhood Cancers
  • Gastrointestinal Cancers
    • Colorectal Cancer
    • Esophageal Cancer
    • Gastrointestinal stromal tumor
    • Liver Cancer
    • Pancreatic Cancer
  • Genitourinary Cancers
    • Bladder Cancer
    • Kidney Cancer
    • Prostate Cancer
  • Gynecologic Cancer
    • Cervical Cancer
    • Ovarian Cancer
  • Head & Neck Cancer
  • Leukemia
    • Acute Myeloid Leukemia
    • CLL
  • Lung Cancer
  • Lymphoma
    • Follicular Lymphoma
    • Mantle Cell Lymphoma
    • Non-Hodgkin Lymphoma
  • Rare Cancers
    • Neuroendocrine Cancer
  • Sarcoma
  • Skin Cancer/Melanoma
  • Thyroid Cancer
Spotlight -
Blogs|
Breast Cancer Webinar Series|
Cancer Horizons|
Clinical Trial Corner|
Heal®|
Publications|
Videos
Advertisement
|Videos|February 11, 2017

The Essentials of Nutrition and Digestive Health in Pancreatic Cancer

Advertisement

Newsletter

Stay up to date on cancer updates, research and education

Subscribe Now!
Advertisement

Related Content

Advertisement
Image of man.

Prostate Cancer Diagnoses Rise as Death Rate Decline Slows

ByRyan Scott
October 8th 2025
Image of man and doctor.

Active Surveillance or Treatment? Your Guide to Stage 1 Prostate Cancer Options

ByGina Mauro
October 3rd 2025
FDA sign image

All FDA Oncology Approvals From September 2025

BySpencer Feldman
October 1st 2025
The FDA approved the denosumab biosimilars Enoby and Xtrenbo for patients on hormone therapies for breast or prostate cancer that weaken bones: © stock.adobe.com.

FDA Approves Enoby and Xtrenbo Biosimilars for Bone Health and Cancer Care

ByRyan Scott
October 1st 2025
Patients with prostate cancer can position themselves to receive the best care possible by being seen by a multidisciplinary team of healthcare providers.

Why Multidisciplinary Care is Crucial in Prostate Cancer

ByDr. Kai Tsao
September 29th 2025
Advertisement
Advertisement

Trending on CURE

1

Patients With Cancer Urged to Ask Questions, Take Notes and Do Their Research

2

Fruzaqla and Tyvyt Combo Shows Improved Outcomes in Advanced Kidney Cancer

3

Navigating Life’s Path With Multiple Myeloma

4

Vonjo Improves Blood Counts in Patients With Myelofibrosis and Anemia

5

What is the Importance of Recognizing Liver Cancer Awareness Month?

  • About Us
  • Advertise / Support
  • Editorial Board
  • Contact Us
  • CancerNetwork.com
  • TargetedOnc.com
  • OncLive.com
  • OncNursingNews.com
  • Terms & Conditions
  • Privacy
  • Do Not Sell My Information
  • Washington My Health My Data
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

609-716-7777

Brand Logo

© 2025 MJH Life Sciences®

All rights reserved.